Disease | ovarian cancer |
Symptom | C0002871|anemia |
Sentences | 5 |
PubMedID- 25918604 | Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity. |
PubMedID- 21381011 | The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival. |
PubMedID- 23266649 | Objective: erythropoiesis-stimulating agents (esas) support chemotherapy-induced anemia in patients with epithelial ovarian cancer (eoc). |
PubMedID- 20361359 | Alkylating agents or antimetabolites were additional significant predictors of anemia in women with ovarian cancer. |
PubMedID- 22123713 | Introduction: to evaluate the incidence of anemia in patients with epithelial ovarian cancer receiving paclitaxel-carboplatin combination therapy (tc) using data from the japanese gynecologic oncology group (jgog) 3016 trial, and to examine the effect of severe anemia on survival during dose-dense tc. |
Page: 1